Skip to main content

August 2015

 

 

academics

 

Clinical research courses

REVIEW: TINOSPORA CORDIFOLIA IN THE TREATMENT OF DEPRESSION

Roche announced that in the large pivotal Phase II study, BIRCH, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) met its primary endpoint and shrank tumours (objective response rate; ORR) in people with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease expressed PD-L1 (Programmed Death Ligand-1). The study showed the amount of PD-L1 expressed by a person’s cancer correlated with their response to the medicine. Adverse events were consistent with what has been previously observed for atezolizumab.

Researchers found that a new combination therapy was highly effective at treating patients with melanoma, which is known as the most serious type of skin cancer. The findings were published online in the Journal of the American Academy of Dermatology.

Nearly 30 per cent of all liver for transplantation is rejected because the donors have 'fatty livers', a disease which is likely to increase in future, the government said. Minister of State for Health Shripad Naik said that the prevalence of non-alcoholic fatty liver disease (NAFLD) is considered to be a known cause of rejection for liver transplantation because of accumulation of fat in the liver.

A survey has found that over 11 per cent people in Delhi are suffering from Asthma and Rhinits, the government today said while acknowledging that air pollution is an "aggravating" factor for respiratory and cardiovascular diseases. "As per a survey conducted by Vallabbhai Patel Chest Institute Delhi in 2006, which covered 5,900 adults belonging to urban, rural and slum population in Delhi, 11.69 per cent were found to be suffering from Rhinits and 11.03 per cent from Asthma," Health Minister J P Nadda informed the Lok °Sabha.

(NewsVoir); India’s leading health app, 1mg has announced the commencement of "Jaankari Hai To Jaan Hai", an awareness campaign aimed at informing consumers of cheaper alternatives when it comes to cancer medication. The company kick started this ambitious campaign on the occasion of Youth Awareness Day organised in New Delhi by Yoddhas, a prominent NGO that helps cancer patients.

A study by Graham Knott at EPFL has successfully used an innovative method, called 'cryofixation', to prevent brain shrinkage during the preparation for electron microscopy. To study the fine structure of the brain, including its connections between neurons, the synapses, scientists must use electron microscopes. However, the tissue must first be fixed to prepare it for this high magnification imaging method. This process causes the brain to shrink; as a result, microscope images can be distorted, e.g. showing neurons to be much closer than they actually are. Scientists have now solved the problem by using a technique that rapidly freezes the brain, preserving its true structure.

Job as Clinical Research Associate at HLL Corporate R&D centre - Enterprise under the Ministry of Health & Family Welfare, Govt. of India

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art  manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: Clinical Research Associate